Formulation and Assessment of Rapidly Disintegrating Tablets of Empagliflozin by Enhancing Dissolution Rate and Bioavailability
DOI:
https://doi.org/10.30904/j.ijrpls.2025.4820Keywords:
Empagliflozin, Mouth Disintegrating Tablets, Superdisintegrants, In Vitro Drug Release, Patient Compliance, UV SpectrophotometryAbstract
This study developed and evaluated mouth disintegrating tablets (MDTs) of Empagliflozin to enhance patient compliance and rapid drug onset. Using UV spectrophotometry (λmax 225nm in 0.1NHCl), MDTs were prepared via direct compression with superdisintegrants SSG, Crospovidone, and Croscarmellose sodium. All formulations met pharmacopeial standards. Batch F-6 with Crospovidone showed the best performance, releasing 99% of the drug within 30 minutes. The findings confirm the effectiveness of a minimal-excipient, direct compression method for efficient Empagliflozin delivery.
Downloads
Published
2025-06-07
Issue
Section
Articles
License
Copyright (c) 2025 Author

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
T P, S. T., Dr. V, A., & Gampa, V. K. (2025). Formulation and Assessment of Rapidly Disintegrating Tablets of Empagliflozin by Enhancing Dissolution Rate and Bioavailability. International Journal of Research in Pharmacy and Life Sciences, 13(1), 31-37. https://doi.org/10.30904/j.ijrpls.2025.4820